Altus Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
375
+64
+21% +$65.4K 0.16% 98
2026
Q1
$286K Buy
311
+24
+8% +$24.3K 0.12% 109
2025
Q4
$308K Buy
287
+4
+1% +$3.83K 0.12% 105
2025
Q3
$216K Sell
283
-11
-4% -$8.19K 0.09% 130
2025
Q2
$229K Sell
294
-58
-16% -$45.1K 0.1% 119
2025
Q1
$291K Hold
352
0.14% 107
2024
Q4
$272K Buy
352
+28
+9% +$23.2K 0.12% 118
2024
Q3
$287K Sell
324
-269
-45% -$242K 0.12% 114
2024
Q2
$537K Sell
593
-21
-3% -$16.8K 0.27% 80
2024
Q1
$478K Buy
614
+17
+3% +$12.1K 0.24% 86
2023
Q4
$348K Buy
597
+4
+0.7% +$2.33K 0.19% 105
2023
Q3
$319K Sell
593
-10
-2% -$5.15K 0.2% 99
2023
Q2
$283K Hold
603
0.17% 113
2023
Q1
$207K Hold
603
0.14% 122
2022
Q4
$221K Buy
+603
New +$214K 0.17% 120
2021
Q1
Sell
-261
Closed -$44K 505
2020
Q4
$44K Buy
+261
New +$39K 0.04% 241

Other funds holding LLY

Altus Wealth Group's LLY Position: Q2 2026 in Review

Altus Wealth Group increased its Eli Lilly (LLY) stake by 21% in Q2 2026, buying an estimated $65.4K and bringing the position to 375 shares worth $450K. The position accounts for 0.16% of the portfolio, ranked #98.

Altus Wealth Group first reported a position in LLY in Q4 2020 and has held it in 16 quarters since. The position peaked at $537K in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Altus Wealth Group held 375 shares of Eli Lilly worth $450K as of Q2 2026.
  • Altus Wealth Group bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 0.16% of Altus Wealth Group's portfolio in Q2 2026, its #98 holding.
  • Altus Wealth Group first reported a position in Eli Lilly in Q4 2020 and has held it in 16 quarters since.
  • Altus Wealth Group's Eli Lilly position peaked at $537K in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Altus Wealth Group's 13F filing for Q2 2026, filed 17 Jul 2026.